News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Combination May Control HIV With Monthly Injections


7/3/2013 6:51:17 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Monthly injections with HIV therapies from GlaxoSmithKline Plc (GSK) and Johnson & Johnson (JNJ) sustained levels of the drugs in blood that should control the virus, according to a study that suggests the shots may one day provide a safer, more convenient treatment option to daily pills.

Help employers find you! Check out all the jobs and post your resume.

Read at Business Week
Read at Seeking Alpha


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES